New Study Suggests that Carnipure(TM) tartrate is Efficient for Post-exercise Stress at Lower Dosages than Previously Determined

Allendale, NJ, April 11, 2007 – Previous research from the University of Connecticut has shown that taking two grams each day of L-Carnitine delivered as Carnipure™ tartrate promotes recovery after exercise. A new study from the same research group released in the February/March 2007 issue of the Journal of Strength and Conditioning Research now demonstrates that taking only one gram each day of L-Carnitine in the form of Carnipure™ tartrate also significantly reduces metabolic stress, minimizes muscle dam-age and promotes recovery after resistance exercise. Carnipure™ tartrate is a high quality L-Carnitine product offered exclusively by Lonza.

“These results further expand on our extensive scientific database testing of Lonza’s Carnipure™ ingredients,” said Kevin Owen, Ph.D., Head of Technical & Scientific Affairs at Lonza.

This study presents highly beneficial and cost-effective results for consumers who take Carnipure™ tartrate as a dietary supplement or in functional food. It supports that con-sumers can obtain an efficient dose of L-Carnitine coming from Carnipure™ tartrate at the “one gram per day” level.

“We are pleased that the finding of the study will allow consumers to enjoy the benefits of Carnipure™ now at a more affordable level,” said Thomas Brancato, NAFTA Head of Marketing and Sales for Lonza’s Nutrition portfolio.
L-Carnitine plays a critical role in fat and energy metabolism. It carries long-chain fatty acids, one of the primary energy sources for our body, into the mitochondria where they are broken down for energy generation. This is especially important for everybody who is leading an active lifestyle and has high energy needs, such as athletes. A vast amount of research has shown that Carnipure™ is beneficial not only for elite athletes, but also for recreational active people.
Lonza is the only manufacturer of the Carnipure™ brand of L-Carnitine products includ-ing Carnipure™ tartrate (U.S. Patent 5073376, Japan Patent JP 2546068 and other international patents). Carnipure™ tartrate consists of 68% pure L-Carnitine and 32% L-tartaric acid and is self affirmed as GRAS (Generally Recognized as Safe). Thanks to a unique production process based on fermentation, Carnipure™ products are produced in a similar enzymatic way as our body produces it. Carnipure™ products are crystalline, white, water-soluble and heat stable which makes them ideal for use in various food and drink applications. In addition, Carnipure™ tartrate is non-hygroscopic, odorless and has a pleasant citrus taste and excellent flowability. Carnipure™ products are kosher certi-fied. Further details are available at

About Lonza
Founded in 1897, Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the pro-duction and support of pharmaceutical active ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharma-ceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preserva-tion, agro and personal care markets. Lonza is headquartered in Basel, Switzerland and is listed on the SWX Swiss Exchange. In 2006 Lonza had sales of CHF 2.91 billion. Further information can be found at

For further information please contact:
Thomas Brancato
Head of NAFTA Sales and Marketing – Nutrition Portfolio
Lonza Inc.
Tel +1 201 316 9304
Fax +1 201 696 3449
[email protected]

Melanie Disa
Corporate Communications Senior Manager
Lonza Inc.
Tel +1 201 316 9413
Fax +1 201 696 3533
[email protected]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.